Delving into the Latest Updates on Zhejiang Hengyan Pharmaceutical Technology Co., Ltd. with Synapse

Overview

主要目的：以浙江恒研医药科技有限公司提供的匹维溴铵片为受试制剂，按生物等效性试验的有关规定，与Abbott Laboratories Limited持证的匹维溴铵片（商品名：Dicetel®/得舒特®，参比制剂）对比在健康人体内的吸收速度及吸收程度，考察两制剂的人体生物等效性。次要目的：观察受试制剂匹维溴铵片和参比制剂匹维溴铵片（Dicetel®/得舒特®）在健康受试者中的安全性。

[Translation]

Main purpose: Using Pinaverium Bromide Tablets provided by Zhejiang Hengyan Pharmaceutical Technology Co., Ltd. as the test preparation, according to the relevant provisions of the bioequivalence test, the absorption rate and degree of Pinaverium Bromide Tablets (trade name: Dicetel®/Deshute®, reference preparation) certified by Abbott Laboratories Limited were compared in healthy humans to investigate the bioequivalence of the two preparations. Secondary purpose: To observe the safety of the test preparation Pinaverium Bromide Tablets and the reference preparation Pinaverium Bromide Tablets (Dicetel®/Deshute®) in healthy subjects.

Start Date23 Dec 2024

Sponsor / Collaborator

Zhejiang Hengyan Pharmaceutical Technology Co., Ltd.

CTR20244164

/ CompletedNot Applicable

艾拉莫德片在健康受试者中随机、开放、单剂量、两制剂、两序列、两周期、交叉对照空腹及餐后状态下的生物等效性研究

[Translation] A randomized, open-label, single-dose, two-formulation, two-sequence, two-period, cross-controlled bioequivalence study of iguratimod tablets in healthy subjects under fasting and fed conditions

主要目的：以浙江恒研医药科技有限公司提供的艾拉莫德片为受试制剂；并以海南先声药业有限公司的艾拉莫德片为参比制剂，进行人体相对生物利用度和生物等效性评价。

[Translation]

Main purpose: To evaluate the relative bioavailability and bioequivalence of Aguratimod tablets provided by Zhejiang Hengyan Pharmaceutical Technology Co., Ltd. as the test preparation and Aguratimod tablets provided by Hainan Xiansheng Pharmaceutical Co., Ltd. as the reference preparation.

Start Date03 Dec 2024

Sponsor / Collaborator

Zhejiang Hengyan Pharmaceutical Technology Co., Ltd.

CTR20244058

/ CompletedNot Applicable

昂丹司琼口溶膜随机、开放、交叉设计在中国健康受试者中的生物等效性研究

[Translation] A randomized, open-label, crossover study of the bioequivalence of ondansetron orodispersible film in Chinese healthy subjects

主要目的：以浙江恒研医药科技有限公司的昂丹司琼口溶膜为受试制剂；并以Norgine Pharmaceuticals Limited持证的昂丹司琼口溶膜为参比制剂，进行生物等效性正式试验。

[Translation]

Main purpose: To conduct a formal bioequivalence study using the ondansetron orodispersible film produced by Zhejiang Hengyan Pharmaceutical Technology Co., Ltd. as the test preparation and the ondansetron orodispersible film produced by Norgine Pharmaceuticals Limited as the reference preparation.

Start Date06 Nov 2024

Sponsor / Collaborator

Zhejiang Hengyan Pharmaceutical Technology Co., Ltd.

100 Clinical Results associated with Zhejiang Hengyan Pharmaceutical Technology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Zhejiang Hengyan Pharmaceutical Technology Co., Ltd.

Login to view more data

100 Deals associated with Zhejiang Hengyan Pharmaceutical Technology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Zhejiang Hengyan Pharmaceutical Technology Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 12 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

IND Approval

1

Login to view more data